tiprankstipranks
Paratek Pharmaceuticals (PRTK)
NASDAQ:PRTK

Paratek Pharmaceuticals (PRTK) Stock Investors

978 Followers
Based on 694,755 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold PRTK
On average, investors allocate 4.48% of their portfolios to PRTK
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding PRTK

4.2%
Last 7
Days
11.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding PRTK, out of 694,755 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

PRTK Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.36%
$2.73
Reduced
2.07%
$2.19
Based on the activity of 12,794 investors who made their portfolios public
The table shows changes in PRTK in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

PRTK Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Roku
5.12%
-0.28%
-1.93%
8.42B
Technology
Micron
5.65%
-0.33%
-2.37%
74.41B
Technology
Coherus Biosciences
2.49%
-0.97%
+810.83%
439.70M
Healthcare
Moderna
5.06%
+0.62%
+0.91%
37.34B
Healthcare
Block
4.20%
+0.20%
+0.43%
24.62B
Technology
Mastercard
5.23%
+0.02%
+0.72%
369.62B
Financial
Assertio Therapeutics
3.14%
-0.86%
-5.92%
240.22M
Healthcare
Snap
9.50%
-0.70%
-5.08%
11.41B
Technology
Shopify
5.34%
+0.05%
-1.17%
61.99B
Technology
Qualcomm
4.65%
-0.26%
+0.34%
122.45B
Technology
Based on the activity of 694,755 active portfolios
Open your Smart Portfolio

PRTK Investor Analysis

PRTK investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
13.3%
of PRTK holders
are under 35
Average Segment Performance
Average P/E Ratio-32.17
Beta9.52
Dividend Yield6.50%
PRTK investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
58.3%
of PRTK holders
are between 35–55
Average Segment Performance
Average P/E Ratio-28.15
Beta14.38
Dividend Yield19.88%
PRTK investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
28.3%
of PRTK holders
are over 55
Average Segment Performance
Average P/E Ratio-21.43
Beta5.95
Dividend Yield6.10%
Overview of age group and performance of PRTK stock investors
See who invests in PRTK according to age group and performance.

FAQ

How many retail Investors hold PRTK?
<0.1% of TipRanks' retail investors hold PRTK in their portfolios.
    What is PRTK Investor Sentiment?
    PRTK’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of PRTK in the last 7 days?
      ▼ 4.2% of TipRanks' retail investors changed their holding of PRTK in the last 7 days.
        What percentage of retail investors changed their holding of PRTK in the last 30 days?
        ▼ 11.7% of TipRanks' retail investors changed their holding of PRTK in the last 30 days.
          What is the average age of retail investors who hold PRTK?
          The average age of PRTK Holders is between 35–55.
            What other stocks have PRTK investors also bought?
            PRTK Investors also bought ROKU, MU, CHRS, MRNA, SQ, MA, ASRT, SNAP, SHOP, QCOM.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ATECAlphatec Holdings
              BSXBoston Scientific
              CNCCentene
              CHRSCoherus Biosciences
              CICigna
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis